266 related articles for article (PubMed ID: 30012308)
1. [Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer].
Garrido P; Aldaz A; Calleja MÁ; de Álava E; Lamas MJ; Martín M; Matías-Guiu X; Palacios J; Vera R
Rev Esp Patol; 2018; 51(3):154-159. PubMed ID: 30012308
[TBL] [Abstract][Full Text] [Related]
2. Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH.
Garrido P; Aldaz A; Calleja MÁ; De Álava E; Lamas MJ; Martín M; Matías-Guiu X; Palacios J; Vera R
Farm Hosp; 2017 Nov; 41(6):688-691. PubMed ID: 29112494
[TBL] [Abstract][Full Text] [Related]
3. Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.
Garrido P; Aldaz A; Vera R; Calleja MA; de Álava E; Martín M; Matías-Guiu X; Palacios J
Clin Transl Oncol; 2018 Apr; 20(4):443-447. PubMed ID: 28861725
[TBL] [Abstract][Full Text] [Related]
4. [Liquid biopsy in oncology: A consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Álvarez-Alegret R; Rojo Todo F; Garrido P; Bellosillo B; Rodríguez-Lescure Á; Rodríguez-Peralto JL; Vera R; de Álava E; García-Campelo R; Remon J
Rev Esp Patol; 2020; 53(4):234-245. PubMed ID: 33012494
[TBL] [Abstract][Full Text] [Related]
5. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
6. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
[TBL] [Abstract][Full Text] [Related]
7. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
8. [Consensus on hereditary cancer between the Spanish Oncology Society and the primary care societies].
Robles L; Balmaña J; Barrel I; Grandes S; Graña B; Guillén C; Marcos H; Ramírez D; Redondo E; Sánchez J
Semergen; 2013; 39(5):259-66. PubMed ID: 23834976
[TBL] [Abstract][Full Text] [Related]
9. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
10. Implementing Precision Medicine in Community-Based Oncology Programs: Three Models.
Levit LA; Kim ES; McAneny BL; Nadauld LD; Levit K; Schenkel C; Schilsky RL
J Oncol Pract; 2019 Jun; 15(6):325-329. PubMed ID: 30802151
[TBL] [Abstract][Full Text] [Related]
11. Partnering with patients in translational oncology research: ethical approach.
Mamzer MF; Duchange N; Darquy S; Marvanne P; Rambaud C; Marsico G; Cerisey C; Scotté F; Burgun A; Badoual C; Laurent-Puig P; Hervé C
J Transl Med; 2017 Apr; 15(1):74. PubMed ID: 28390420
[TBL] [Abstract][Full Text] [Related]
12. Precision Medicine: Accelerating the Science to Revolutionize Cancer Care
.
Brant JM; Mayer DK
Clin J Oncol Nurs; 2017 Dec; 21(6):722-729. PubMed ID: 29149123
[TBL] [Abstract][Full Text] [Related]
13. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP).
Gargallo P; Bautista F; Juan-Ribelles A; Izquierdo E; Soriano A; de Rojas T; Escudero A; Lavarino C; Solano P; Hladun R; Rubio-San-Simón A; Martínez-Romera I; Calabria I; Olaciregui NG; Castañeda-Heredia A; de Álava E; Pérez-Martínez A; Astigarraga I; Patiño-García A; Alonso J; Fernández-Teijeiro A; Cañete A; Moreno L
Clin Transl Oncol; 2022 May; 24(5):809-815. PubMed ID: 35152364
[TBL] [Abstract][Full Text] [Related]
14. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
Walko C; Kiel PJ; Kolesar J
Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
[TBL] [Abstract][Full Text] [Related]
15. [Healthcare of children and adolescents in national strategy for action for children for 2012-2017].
Kuchma VR
Gig Sanit; 2013; (6):26-30. PubMed ID: 24624816
[TBL] [Abstract][Full Text] [Related]
16. Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals.
Fasola G; Barducci MC; Pelizzari G; Grossi F; Pinto C; Daniele B; Giordano M; Ortega C; Silva RR; Tozzi VD; Cavanna L; Aprile G
Oncologist; 2023 Jun; 28(6):e324-e330. PubMed ID: 36848261
[TBL] [Abstract][Full Text] [Related]
17. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
18. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
19. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
Ersek JL; Black LJ; Thompson MA; Kim ES
Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
[TBL] [Abstract][Full Text] [Related]
20. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
Arnall JR; Petro R; Patel JN; Kennedy L
J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
